HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Twenty-Three-Gauge Pars Plana Vitrectomy With Inferior Retinectomy and Postoperative Perfluoro-n-Octane Retention for Retinal Detachment Repair.

AbstractPURPOSE:
The objective of this article was to study outcomes following use of perfluoro-n-octane (PFO) as a short-term postoperative vitreous substitute in patients undergoing pars plana vitrectomy for a recurrent rhegmatogenous retinal detachment (RRD) with advanced proliferative vitreoretinopathy requiring an inferior retinectomy.
DESIGN:
A retrospective consecutive chart review.
METHODS:
The charts of subjects who underwent RRD repair by pars plana vitrectomy with short-term postoperative PFO, vitreous substitution were retrospectively reviewed. The primary outcome was the anatomic success rate following retinectomy and short-term PFO retention. The secondary outcomes were change in best corrected visual acuity (BCVA) and occurrence of complications related to short-term PFO retention.
RESULTS:
The anatomic success rate at the final follow-up was 91.7% (11/12). A total of 7 (58.3%; confidence interval, 32%-80.7%) of 12 patients achieved a final BCVA better than initial BCVA. There were no significant complications related to short-term PFO retention.
CONCLUSIONS:
Perfluoro-n-octane is efficacious and safe as a short-term vitreous substitute for repair of a recurrent RRD with advanced proliferative vitreoretinopathy requiring an inferior retinectomy.
AuthorsRyan B Rush, Matthew P Simunovic, Alex P Hunyor
JournalAsia-Pacific journal of ophthalmology (Philadelphia, Pa.) (Asia Pac J Ophthalmol (Phila)) 2013 Jul-Aug Vol. 2 Issue 4 Pg. 232-6 ISSN: 2162-0989 [Electronic] China
PMID26106917 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: